Delivery Order SPE2DB22D3016-SPE2DB25FAWM5

Award Date 5/15/25
Potential Completion Date 5/16/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, a pharmaceutical product. The contract has a ceiling value of $6,873.12 and a completion date of February 10, 2025. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract award, valued at $1,176.75, is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 100S. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it has an ultimate completion date of March 19, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,446.06, is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, with a period of performance through April 4, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, with a ceiling value of $4,158.77 and a completion date of February 7, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a firm fixed price of $2,033.85 and a completion date of January 10, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S. The order has a ceiling value of $1,171.36 and a completion date of March 8, 2024. The contract is a Firm Fixed Price arrangement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,673.08, is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of December 13, 2023. The award is not designated with a set-aside. Amerisourcebergen holds a significant...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide TAMSULOSIN HCL 0.4 MG CAPSULE 1000S to the U.S. Department of Defense. The contract, valued at $2,502.84, is a Delivery Order with a Firm Fixed Price pricing type. It has an ultimate completion date of June 20, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to...
This is a federal delivery order contract award to AmerisourceBergen Drug Corp for the supply of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, a pharmaceutical product. The contract has a firm fixed price of $33,992.27 and a completion date of September 26, 2023. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides medical supplies and pharmaceuticals to military and veterans' healthcare programs. AmerisourceBergen is a major...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,623.49, is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, a medication used to treat benign prostatic hyperplasia. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 19, 2025. This award is not designated as a set-aside...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAWM5
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, a prescription medication, with a firm fixed price ceiling value of $2,345.52 and a completion date of May 16, 2025. The contract is a delivery order and is not set aside for any specific business type. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the DLA. The company holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 8/14/25, 10:02 AM